463 related articles for article (PubMed ID: 17097500)
21. Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension.
Ghofrani HA; Rose F; Schermuly RT; Olschewski H; Wiedemann R; Kreckel A; Weissmann N; Ghofrani S; Enke B; Seeger W; Grimminger F
J Am Coll Cardiol; 2003 Jul; 42(1):158-64. PubMed ID: 12849677
[TBL] [Abstract][Full Text] [Related]
22. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
Lunze K; Gilbert N; Mebus S; Miera O; Fehske W; Uhlemann F; Mühler EG; Ewert P; Lange PE; Berger F; Schulze-Neick I
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():32-8. PubMed ID: 16919008
[TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
Launay D; Sitbon O; Le Pavec J; Savale L; Tchérakian C; Yaïci A; Achouh L; Parent F; Jais X; Simonneau G; Humbert M
Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.
Gomberg-Maitland M; McLaughlin V; Gulati M; Rich S
Am J Cardiol; 2005 Nov; 96(9):1334-6. PubMed ID: 16253609
[TBL] [Abstract][Full Text] [Related]
26. Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy.
Bhatia S; Frantz RP; Severson CJ; Durst LA; McGoon MD
Mayo Clin Proc; 2003 Oct; 78(10):1207-13. PubMed ID: 14531479
[TBL] [Abstract][Full Text] [Related]
27. One year efficacy and safety of oral sildenafil treatment in severe pulmonary hypertension.
Samarzija M; Zuljević E; Jakopović M; Sever B; Knezević A; Dumija Z; Vidjak V; Samija M
Coll Antropol; 2009 Sep; 33(3):799-803. PubMed ID: 19860106
[TBL] [Abstract][Full Text] [Related]
28. Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension.
Onen ZP; Akkoca Yildiz O; Eriş Gülbay B; Karabiyikoğlu G
Tuberk Toraks; 2006; 54(2):177-81. PubMed ID: 16924576
[TBL] [Abstract][Full Text] [Related]
29. A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease.
Madden BP; Allenby M; Loke TK; Sheth A
Vascul Pharmacol; 2006 May; 44(5):372-6. PubMed ID: 16574495
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.
Derchi G; Forni GL; Formisano F; Cappellini MD; Galanello R; D'Ascola G; Bina P; Magnano C; Lamagna M
Haematologica; 2005 Apr; 90(4):452-8. PubMed ID: 15820939
[TBL] [Abstract][Full Text] [Related]
31. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
[TBL] [Abstract][Full Text] [Related]
32. Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension.
Rosengarten B; Schermuly RT; Voswinckel R; Kohstall MG; Olschewski H; Weissmann N; Seeger W; Kaps M; Grimminger F; Ghofrani HA
Cerebrovasc Dis; 2006; 21(3):194-200. PubMed ID: 16388195
[TBL] [Abstract][Full Text] [Related]
33. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
Badesch DB; Hill NS; Burgess G; Rubin LJ; Barst RJ; Galiè N; Simonneau G;
J Rheumatol; 2007 Dec; 34(12):2417-22. PubMed ID: 17985403
[TBL] [Abstract][Full Text] [Related]
34. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
Lewis GD; Lachmann J; Camuso J; Lepore JJ; Shin J; Martinovic ME; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Jan; 115(1):59-66. PubMed ID: 17179022
[TBL] [Abstract][Full Text] [Related]
35. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
36. Low-dose oral sildenafil for patients with pulmonary hypertension: a cost-effective solution in countries with limited resources.
Vida VL; Gaitan G; Quezada E; Barnoya J; Castañeda AR
Cardiol Young; 2007 Feb; 17(1):72-7. PubMed ID: 17184573
[TBL] [Abstract][Full Text] [Related]
37. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
[TBL] [Abstract][Full Text] [Related]
38. Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study.
Zhang ZN; Jiang X; Zhang R; Li XL; Wu BX; Zhao QH; Wang Y; Dai LZ; Pan L; Gomberg-Maitland M; Jing ZC
Heart; 2011 Nov; 97(22):1876-81. PubMed ID: 21948962
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil?
Milman N; Burton CM; Iversen M; Videbaek R; Jensen CV; Carlsen J
J Heart Lung Transplant; 2008 Mar; 27(3):329-34. PubMed ID: 18342757
[TBL] [Abstract][Full Text] [Related]
40. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study.
Humpl T; Reyes JT; Holtby H; Stephens D; Adatia I
Circulation; 2005 Jun; 111(24):3274-80. PubMed ID: 15956137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
